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reflection Fourier‑transform 
infrared (ATR‑FTIR) spectroscopy 
and multivariate analysis
Emanuelly Bernardes‑Oliveira 1*, Daniel Lucas Dantas de Freitas 2,  
Camilo de Lelis Medeiros de Morais 3,4, Maria da Conceição de Mesquita Cornetta 5,  
Juliana Dantas de Araújo Santos Camargo 5, Kassio Michell Gomes de Lima 2 & 
Janaina Cristiana de Oliveira Crispim 1,5*
Gestational diabetes mellitus (GDM) is a hyperglycaemic imbalance first recognized during pregnancy, 
and affects up to 22% of pregnancies worldwide, bringing negative maternal–fetal consequences in 
the short‑ and long‑term. In order to better characterize GDM in pregnant women, 100 blood plasma 
samples (50 GDM and 50 healthy pregnant control group) were submitted Attenuated Total Reflection 
Fourier‑transform infrared (ATR‑FTIR) spectroscopy, using chemometric approaches, including feature 
selection algorithms associated with discriminant analysis, such as Linear Discriminant Analysis 
(LDA), Quadratic Discriminant Analysis (QDA) and Support Vector Machines (SVM), analyzed in the 
biofingerprint region between 1800 and 900 cm−1 followed by Savitzky–Golay smoothing, baseline 
correction and normalization to Amide‑I band (~ 1650 cm−1). An initial exploratory analysis of the data 
by Principal Component Analysis (PCA) showed a separation tendency between the two groups, which 
were then classified by supervised algorithms. Overall, the results obtained by Genetic Algorithm 
Linear Discriminant Analysis (GA‑LDA) were the most satisfactory, with an accuracy, sensitivity and 
specificity of 100%. The spectral features responsible for group differentiation were attributed mainly 
to the lipid/protein regions (1462–1747 cm−1). These findings demonstrate, for the first time, the 
potential of ATR‑FTIR spectroscopy combined with multivariate analysis as a screening tool for fast 
and low‑cost GDM detection.
Gestational diabetes mellitus (GDM) is a hyperglycaemic metabolic disorder that first appears during pregnancy 
and does not meet the criteria for manifest  diabetes1, it is characterized by glucose intolerance or beta cell dys-
function and insulin resistance, and affects up to 22% of all pregnancies  worldwide2.
One of the protocols that is most used in the diagnosis of GDM follows the recommendations of the Ameri-
can Diabetes Association (ADA)3. In addition to hyperglycemia, other glycemic markers have been used for the 
diagnosis of diabetes mellitus (DM), including fructosamine, glycated albumin, hemoglobin A1c (HbA1c), and 
1,5-anhydroglucite, each with its own limitation, if we consider cost for countries in  development4. Despite this 
approach, several researchers are looking for new possibilities to identify women at risk for GDM, particularly 
in the first trimester.
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It is known that GDM is considered a risk factor associated with many perinatal morbidities that affect 
maternal and foetal/neonatal  health1. GDM promotes increased weight and triglyceride levels, changes in blood 
pressure, heart problems, induction of caesarean section, and type II diabetes after childbirth in women. For 
new-borns, the most common risks are weight gain (macrosomia), shoulder dystocia at birth, congenital heart 
defects, hyperbilirubinemia, polycythemia, respiratory distress and stillbirth, in addition to the risk of develop-
ing metabolic  syndrome5,6.
Individuals with GDM during pregnancy are known to suffer physiological changes, with the appearance of 
diabetogenic placental hormones (oestrogen and progesterone), placental factors (human placental lactogen), and 
increased lipids and adipokines including leptin, resistin and visfatin from the first trimester. These contribute 
to the predisposition of metabolic diseases and insulin resistance, obesity and chronic inflammation capable of 
releasing different pro-inflammatory cytokines and C-reactive proteins (CRP), especially when these women 
are  obese7.
In regard to the contribution of biomolecules in the pathophysiology of GDM, this is not yet well known, 
however, recent studies have shown that the levels of Growth differentiation factor 15 (GDF15), also known as 
macrophage inhibitory cytokine-1 (MIC-1), are highly expressed the placenta, and this is identified as a pleio-
tropic protein that plays key roles in prenatal development, induced by both acute and chronic inflammatory 
states, acting directly on metabolism of carbohydrates and lipids of GDM  women8,9. Due to the metabolic impact 
of GDM during pregnancy, screening and appropriate management of GDM is essential, especially in the first 
weeks of pregnancy, aiming at improving the quality of prenatal care of these women. The diagnosis of GDM 
and early intervention is of great significance for reducing short- and long-term consequences for the moth-
ers and new-borns10. This is critical in less developed countries, where most pregnant women do not have the 
opportunity to perform early GDM diagnosis.
Therefore, there is a need for accurate and low-cost techniques for GDM detection. Attenuated total reflection 
Fourier-transform infrared (ATR-FTIR) spectroscopy can be used to extract spectrochemical information of 
biological samples, where signals of vibrational motions existing in the chemical bonds of these biomolecules can 
be captured, hence, generating an important biofingerprint spectrum in the region between 1800 and 900 cm−1 
where many important biomolecules (DNA/RNA, lipids, proteins and carbohydrates) have contributing meta-
bolic features relating to disease  appearance11.
Chemometric methods are often employed to analyse complex spectral data acquired with ATR-FTIR spec-
troscopy. Feature extraction and selection methods, such as principal component analysis (PCA), successive 
projections algorithm (SPA) and genetic algorithm (GA) can be employed to reduce data complexity and redun-
dant  information12. PCA is an exploratory analysis algorithm capable of reducing the original data into a low 
number of principal components (PCs), where each PC represents a piece of the original data  variance11, while 
SPA and GA are able to select the most significant wavenumbers from the spectral dataset responsible for class 
 differentiation13. These algorithms are commonly associated with linear discriminant analysis (LDA), quadratic 
discriminant analysis (QDA) and support vector machines (SVM). These classification algorithms are used to 
build supervised training models which allow us to predict unknown samples based on their spectral  response12.
ATR-FTIR together with chemometric methods has played an increasingly important role in the field of 
medical and biological analysis, through quickly detecting pathological conditions, even at very early stages.
Previous studies have demonstrated the importance of using infrared spectroscopy in samples of biological 
diabetics when analyzing glycation in nail clippings. These studies have shown that ATR-FTIR is sensitive enough 
to analyze the presence of glucose when compared to the reference  population14. ATR-FTIR also demonstrated 
its use in the diagnosis of diseases such as  cancer15, neurodegenerative  diseases16, zika and  chikungunya17 and 
chronic  diseases18, as well as in analyzing blood plasma, and managing to separate the disease group from the 
healthy group, via biomolecules.
Material and methods
Study design and population. We performed a case–control study, conducted in a Reference Obstetrics 
and Gynecology Hospital between January and October 2018. A total of 50 GDM women were recruited, all 
with single pregnancy at a gestational age of between 12 and 38 weeks. Only participants with complete clinical 
information were included in the analysis. Subjects were excluded if they had had chronic medical conditions, 
including hypertension, were declared diabetic (blood glucose ≥ 126 mg/dL), had type 2 diabetes mellitus, and 
heart or kidney diseases. The study was approved by the Ethics Committee of Federal University of Rio Grande 
do Norte. Written informed consent was obtained from every participant. All procedures were performed in 
compliance with the Declaration of Helsinki.
Clinical measurements. Baseline anthropometric measurements were completed at recruitment using a 
standardized protocol for BMI classification by week of gestation, the classifications were: underweight, adequate 
weight, overweight and obesity. Clinical data were collected from medical record reviews. Pregnant women 
in the GDM group were already diagnosed with blood glucose changes between ≥ 92 mg/dL and < 126 mg/dL 
during prenatal care, while patients with blood glucose ≥ 126 mg/dL were considered to be declared diabetic, 
according to the guidelines of the American Diabetes Association (ADA)3. These women were given medical 
nutrition therapy and/or insulin treatment during their antenatal follow-up. The anthropometric, socioepide-
miological and metabolic characteristics of GDM and glucose samples were summarized in Table 3.
Healthy pregnant control group. Fifty healthy pregnant women were enrolled who attended a low-risk 
maternity hospital. The pregnant women were between 19 and 44 years old, and at a gestational age of between 
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9 and 39 weeks. The healthy pregnant control group had blood glucose < 92 mg/dL and all underwent fasting 
glucose testing and oral glucose tolerance test (OGTT) screening at 24–28 weeks to discard GDM.
Sample collection and determination for analysis with ATR‑FTIR. Venous blood samples were 
collected from participants following an overnight fast 8 h. After 4 h the blood samples were centrifugated at 
3600 rpm for 7 min to separate erythrocytes from blood plasma. 100 µL aliquots of plasma were transferred to 
eppendorf tubes and stored at − 80 °C until ATR-FTIR analysis. The blood plasma glucose levels were deter-
mined as described in Table 3.
ATR‑FTIR spectroscopy. The blood plasma samples were thawed at room temperature for 30–40  min, 
[n = 100 samples (GDM group = 50) and (healthy pregnant control group = 50)], where 10 μL aliquots (in trip-
licates) were used for analysis. The spectral data were acquired using a IRAffinity-1S FTIR spectrophotometer 
(Shimadzu Corp., Japan) equipped with an ATR.
The instrument was set up to perform a total of 32 scans with 4 cm−1 spectral resolution for both background 
and sample spectra, recorded rapidly at the range between 4000 and 600 cm−1, as described by Santos et al. with 
some  modifications17.
Data analysis. The data analysis was performed in MATLAB R2014b environment version 8.4 (MathWorks, 
Inc., USA). The raw spectral data was loaded and pre-processed by cutting the biofingerprint region between 
1800 and 900 cm−1, followed by Savitzky–Golay (SG) smoothing (window of 15 points, 2nd order polynomial 
fitting), automatic weighted least squares (AWLS) baseline correction and normalisation to the Amide I band 
(1650 cm−1). The data were mean-centred before analysis.
Samples were divided into training (70%), validation (15%) and test (15%) sets for all classification models 
by applying the Kennard–Stone (KS)  algorithm19 to the pre-processed spectra. The training set was used in the 
modelling procedure, the validation set for internal model optimisation, and the test set was only used in the 
final classification evaluation. Initially, the data were analysed by principal component analysis (PCA). Each PC 
is composed of scores (variance in sample direction) and loadings (variance in wavenumber direction), where the 
scores are used to assess similarities/dissimilarities between the samples, and the loadings show the weight of each 
wavenumber towards the scores pattern. The PCA decomposition of a spectral dataset X takes the following form:
where T is the scores matrix; P is the loadings matrix; and E is the residual matrix. The PCA scores were used 
for exploratory analysis of the data, and as input data for supervised classification models: linear discriminant 
analysis (LDA), quadratic discriminant analysis (QDA), and support vector machines (SVM).
In addition to PCA, the spectral dataset were reduced to a few spectral features by feature selection methods: 
genetic algorithm (GA) and successive projections algorithm (SPA). These were coupled to LDA, QDA and 
SVM for classification, and their performances were compared with the PCA-based approaches.  GA20 is a type 
of variable selection algorithm that performs this task by mimicking the evolution process, thus recombining 
and promoting mutations in different subsets of variables until a determined fitness criterion is reached. The 
goal of this algorithm is to reduce the total number of variables without changing the type of variable, as occurs 
when using data reduction via PCA. In this case, GA was used with 100 generations and 200 chromosomes each, 
and mutation and crossover probabilities were set to 10% and 60%, respectively.  SPA21 also works by reducing 
the pre-processed spectral data to a low number of variables maintaining the original spectral information. It 
works with an iterative process by projecting the spectral variables and selecting those which minimise the data 
collinearity. The optimum number of variables for SPA and GA was determined by the minimum cost function 
G calculated for the validation set as  follow10:
where NV  is the number of validation samples and gn  is defined as:
where r2(xn,mI(n)) is the squared Mahalanobis distance between the object xn (of class I(n) ) and the centre of its 
true class ( mI(m) ), and r2
(
Xn,mI(m)
)
 is the squared Mahalanobis distance between the object Xn and the centre 
of the closest wrong class ( mI(m)).
Like the PCA scores, the selected wavenumbers by GA and SPA were used as input variables for LDA, QDA 
and SVM. LDA and QDA are discriminant analysis algorithms based on a Mahalanobis distance calculation 
between the classes, where LDA assumes classes have similar variance structures, thus, using a pooled covariance 
matrix for distance calculation; while QDA assumes classes have different variance structures, and thus uses the 
individual variance–covariance matrix for each class in the distance  calculation22 SVM is a linear classification 
algorithm that uses a non-linear step called the kernel  transformation23. The kernel function (in this case, the 
radial bases function (RBF)) transforms the input spectral data into a feature space that maximises the margin 
of separation between the classes. Although more powerful than LDA or QDA for classification, SVM is more 
susceptible to  overfitting24.
X = TPT + E
(2)G =
1
NV
∑NV
n=1
gn
(3)gn =
r2
(
xn,mI(n)
)
minI(m)�=I(n)r2
(
Xn,mI(m)
)
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Model quality evaluation. Model accuracy, sensitivity and specificity were calculated for the test set in 
order to evaluate the classification performance and validate the models. The accuracy (AC) represents the total 
number of samples correctly classified; the sensitivity (SENS) and specificity (SPEC) measure the proportion of 
positives and negatives that are correctly identified, respectively. These metrics are calculated as  follows25:
where TP stands for true positive; TN for true negative; FP for false positive; and FN for false negative.
Results
ATR-FTIR is considered a valuable tool capable of analysing different types of diseases by measuring biological-
derived samples. Therefore, we used this technique in order to analyse the specificity, sensitivity and accuracy 
when differentiating the GDM group.
The raw ATR-FTIR mean spectra of GDM vs. healthy pregnancy control groups are shown in Fig. 1A. The 
data set consists of 100 samples of blood plasma, 50 samples of GDM group and 50 samples of healthy pregnancy 
control group. For each sample, the acquisition of 3 spectra was done, giving a total of 300 spectra. In the region 
of interest between 1800 and 900 cm−1, known as the biofingerprint region, some characteristic IR absorption 
bands can be observed in the spectra, such as the major peaks at ~ 1650 cm−1 for Amide I of proteins, as well as 
methylene groups of lipids at ~ 1750 cm−126.
The spectral data were pre-processed by Savitzky–Golay smoothing, baseline correction and normalisation 
to the Amide I band (~ 1650 cm−1) (Fig. 1B). The spectra present strong similarity related to absorption bands, 
in addition to being highly overlapped, in a way that it becomes difficult to categorise samples only consider-
ing the visual spectral information available. In this sense, application of multivariate algorithms is an essential 
strategy to extract important spectral information, allowing for the discrimination between samples of GDM vs. 
healthy pregnancy control groups based on their pathophysiological condition reflected in the spectral features. 
Furthermore, variable selection algorithms are powerful tools used to search for biomarkers in blood plasma, 
allowing less complex models to be obtained.
To predict whether pregnant women are affected by GDM, it is necessary to use chemometric models capable 
of finding spectral features that differentiate GDM spectra with the healthy pregnancy control group spectra. 
Initially, a PCA model was performed for exploratory analysis of the data, as shown in Fig. 2. Three principal 
components (PCs) were used, accounting for > 90% of cumulative explained variance.
The PC1 (68.18% explained variance) vs. PC2 (16.56% explained variance) scores plot (Fig. 2A), PC1 (68.18% 
explained variance) vs. PC3 (7.16% explained variance) scores plot (Fig. 2B), and the show some visual distinc-
tion between GDM and healthy pregnancy control groups; while the PC2 (16.56% explained variance) vs. PC3 
(7.16% explained variance) scores plot (Fig. 2C) was much able to efficiently differentiate the sample groups, 
showing that a low percentage of spectral variance is responsible for class separation.
The PCA loadings are shown in Fig. 2D, where the following spectral features were found to have higher 
absolute coefficients, thus being responsible for the segregation pattern observed in the PCA scores plot. PC1 and 
PC2 show very similar loading profiles, with many overlapping bands between 900 to 1500 cm−1, and a mirror-
ing profile between 1500 and 1700 cm−1; while PC3 shows quite a distinctive loading profile from PC1 and PC2.
Supervised classification models were built for systematic discrimination of GDM and healthy pregnancy 
control groups. For this, the pre-processed spectral data were split into training (70%), validation (15%) and 
test (15%) sets using the Kennard-Stone (KS) uniform sample selection algorithm. Several classification algo-
rithms were tested (Table 1), where figures of merit were calculated for the test set: accuracy (AC) (percentage 
of total correct classification), sensitivity (SENS) (percentage of correct classification for the GDM group), and 
specificity (SPEC) (percentage of correct classification for the healthy pregnancy control group). The genetic 
algorithm linear discriminant analysis (GA-LDA) model achieved the best classification results, with 100% 
accuracy, sensitivity and specificity for the test set. GA-LDA Fisher’s discriminant scores (Fig. 3A,B) show an 
almost complete separation for all samples (training, validation and test sets) (Fig. 3A), and a perfect separation 
for the test samples (Fig. 3B). Where GA-LDA selected 10 spectral wavenumbers which were responsible for 
group differentiation, principally associated with the regions for water (901; 1047 cm−1) and lipid/protein regions 
(1462; 1539; 1560; 1582; 1645; 1661; 1693; 1747 cm−1) (Fig. 3C). The tentative biochemical assignments of these 
variables based on Movasaghi et al.26 are shown in Table 2.
While still analyzing the characteristics of both groups, in the present study it was possible to verify some 
differences in relation to demographic, clinical and obstetric data, as shown in Table 3. Most pregnant women 
with GDM were older and had previous pregnancies when compared to the healthy pregnancy control group 
(p < 0.05). When analyzing fasting blood glucose, the GDM group was statistically significant when compared to 
the healthy pregnancy control group (p < 0.05). The mean BMI of the GDM group was higher (30.78 ± 5.00), com-
pared to healthy pregnancy control group (28.24 ± 4.09), and they presented obesity or were overweight (p < 0.05).
(4)AC (% ) =
(
TP+ TN
TP+ FP+ TN+ FN
)
× 100
(5)SENS (% ) =
(
TP
TP+ FN
)
× 100
(6)SPEC (% ) =
(
TN
TN+ FP
)
× 100
5
Vol.:(0123456789)
Scientific Reports |        (2020) 10:19259  | https://doi.org/10.1038/s41598-020-75539-y
www.nature.com/scientificreports/
Discussion
The development of a novel tool for the diagnosis of different diseases is extremely important, principally when 
they affect women during pregnancy, as is the case with GDM which is capable of harming both the mother 
and the fetus.
ATR-FTIR is considered a powerful tool, as it analyzes different biological structures based on spectral analy-
sis, proving to be of great use to health clinical, promoting future perspectives through technological  advances11.
In our study, blood plasma from 100 pregnant women (50 GDM and 50 healthy control group) was analyzed 
by ATR-FTIR spectroscopy, in order to predict GDM group based on their samples’ spectrochemical profile. Our 
data showed that unsupervised model PCA was able to show a discriminating pattern between the groups, gen-
erating better scores between the PCs (PC2 vs. PC3). In PC3, the main difference is the amount of protein versus 
Figure 1.  (A) Mean raw FTIR spectra for GDM and healthy controls; and (B) mean pre-processed spectra 
(Savitzky–Golay smoothing, baseline correction and normalisation to the Amide I band) for GDM and healthy 
controls in the biofingerprint region (1800–900 cm−1).
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water. The negative loading appears around 1635 cm−1 (water band). This appears oppositely correlated with the 
Amide II indicating a difference in the protein/water ratio between the two groupings. PC2 and PC3 show a great 
scores difference between the samples groups, indicating their respective loadings on PC1 and PC2 can be used 
to identify spectral markers associated with class differences. The spectral regions around 1640 cm−1, near the 
water band, showed one of the highest absolute loadings indicating that water is a discriminating feature between 
the samples. However, Caixeta et al.27, when analyzing saliva samples of male wistar rats with DM (treated with 
insulin), pre-diabetic and healthy, demonstrated the applicability of the ATR-FTIR associated with PCA-LDA, 
where it was able to generate six PCs, demonstrating the effectiveness of using mathematical algorithms in 
monitoring DM. Moreover, in a recent study analyzing peripheral blood samples from pre-diabetic patients, a 
response was found to glucose levels when using ATR-FTIR and PCA combined with eXtreme Gradient Boost-
ing (XGBoost) generating the model SG-PCA-XGBoost, which was able to differentiate from healthy  people18.
When we used different supervised models, GA-LDA was the best classification model that systematically 
distinguished GDM samples from controls. GA-LDA is a powerful feature selection algorithm based on itera-
tive combinations inspired by Mendelian genetics, where the fittest variables (wavenumbers) that maximize 
class separation are  selected13. It commonly outperforms feature extraction methods such as  PCA28. However, 
Figure 2.  PCA scores plot on (A) PC1 vs. PC2, (B) PC1 vs. PC3 and (C) PC2 vs. PC3. (D) PCA loadings on 
PC1, PC2 and PC3. Percentage inside parenthesis: explained variance.
Table 1.  Quality parameters for the test set. AC accuracy, SENS sensitivity, SPEC specificity.
Parameter
PCA SPA GA
LDA QDA SVM LDA QDA SVM LDA QDA SVM
AC (%) 83.3 86.7 90.0 90.0 83.3 90.0 100 96.7 86.7
SENS (%) 80.0 100 80.0 93.3 100 80.0 100 100 73.3
SPEC (%) 86.7 73.3 100 86.7 66.7 100 100 93.3 100
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Figure 3.  (A) GA-LDA discriminant function for all samples (training, validation and test sets); (B) GA-LDA 
discriminant function for the test set only; and (C) GA-LDA selected variables.
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there are few studies that address the use of the ATR-FTIR tool in diabetes, and fewer with GDM. Until this 
moment, no study has analyzed blood plasma samples from pregnant women with GDM in GA-LDA models. 
This demonstrates the innovation of this model in the prediction of GDM, and confirms that GA-LDA is an 
excellent classification algorithm for samples of blood plasma of pregnant women, playing a fundamental role 
during prenatal care, assisting in diagnosis and monitoring.
Table 2.  Selected wavenumbers by the GA-LDA to distinguish GDM and controls samples.
Selected wavenumber  (cm−1) Tentative assignment
901 Phosphodiester stretching bands region (for absorbances due to collagen and glycogen)
1047 Glycogen band (due to OH stretching coupled with bending)
1462 CH2 scissoring mode of the acyl chain of lipid
1539 Protein amide II absorption- predominately b-sheet of amide II
1560 Ring base mode
1582 Ring C–C stretch
1645 Amide I
1661 Amide I
1693 High frequency vibration of an antiparallel β-sheet of Amide I
1747 ν(C=O) (polysaccharides, pectin)
Table 3.  Demographic factors, clinical and obstetric history of pregnant women with and without diagnosis 
of GDM. Continuous data are expressed as Mean ± Standard deviation/median and 25th and 75th percentiles. 
Categorical data are expressed as absolute (n) and relative (%) frequency. Values in bold indicate significance 
at p < 0.05. GDM Gestational diabetes mellitus, qty. quantity, BMI Body Mass Index. a Significance of difference 
between groups by Student’s t-test or Mann–Whitney U test (continuous variables) or Pearson’s chi-square test 
or Fisher’s test (categorical variables).
Variables Group p  valuea Total
GDM Control
N, % 50 (50.0%) 50 (50.0%) 100 (100.0%)
Age, years 32 (28–35) 28 (24–35) 0.046 31 (25–35)
Age (≥ 35 anos), n (%) 13 (26.0%) 13 (26.0%) 1.000 26 (26.0%)
Fasting blood glucose, mg/dl 98 (95–107) 79 (73–87) p < 0.01 92 (79–98)
BMI, kg/m 30.78 ± 5.00 28.24 ± 4.09 0.006 29.51 ± 4.72
BMI, n (%)
Suitable 8 (16.0%) 25 (50.0%) 0.002 33 (33.0%)
Low weight 3 (6.0%) 3 (6.0%) 6 (6.0%)
Overweight 21 (42.0%) 15 (30.0%) 36 (36.0%)
Obesity 18 (36.0%) 7 (14.0%) 25 (25.0%)
Obesity or overweight, n (%) 39 (78.0%) 22 (44.0%) p < 0.01 61 (61.0%)
Marital status, n (%)
Single or divorced 19 (38.0%) 35 (70.0%) 0.001 54 (54.0%)
Married or stable union 31 (62.0%) 15 (30.0%) 46 (46.0%)
Has children, n (%)
Yes 40 (80.0%) 29 (58.0%) 0.017 69 (69.0%)
No 10 (20.0%) 21 (42.0%) 31 (31.0%)
Number of children 1 (1–2) 1 (0–2) 0.107 1 (0–2)
Had previous pregnancy, n (%) 49 (98.0%) 48 (96.0%) 1.000 97 (97.0%)
Previous pregnancies, qty 3 (2–4) 2 (1–3) 0.110 2 (1–3)
Miscarriage History, n (%) 19 (38.0%) 18 (36.0%) 0.836 37 (37.0%)
Last delivery type, n (%)
Cesarean 12 (24.0%) 14 (28.0%) 0.100 26 (26.0%)
Vaginal 28 (56.0%) 18 (36.0%) 46 (46.0%)
First birth 10 (20.0%) 18 (36.0%) 28 (28.0%)
Own GDM history, n (%) 2 (4.0%) 1 (2.0%) 1.000 3 (3.0%)
Family history of GDM, n (%) 31 (62.0%) 30 (60.0%) 0.838 61 (61.0%)
History of disease in previous pregnancy, n (%) 11 (22.0%) 7 (14.0%) 0.298 18 (18.0%)
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Although many studies on the pathophysiology of GDM have been conducted, the potential of biomarkers 
in its development remains unclear. In our study it was possible to verify that the selected wavenumbers by GA-
LDA were responsible for group separation, according to the biomolecule regions referring to lipid and protein/
water ratio. This information combined with the GA-LDA selected wavenumbers at 1046 cm−1, 1537 cm−1 and 
1640 cm−1 indicate that some relation between water and protein levels is a discriminant factor between the 
groups.
However, GDM emerges as a disorder of insulin-dependent, where metabolomic pathways are relevant to 
lipid and amino acid metabolisms, as well as bile acids and abnormal protein  turnover29. Promotion of oxidation 
of protein intensifies during GDM, in which the hyperglycemic state causes protein hydroperoxides, protein car-
bonyls, C-reactive protein and glycated hemoglobin (HbA1c). In addition to this, it is considered an important 
mediator of adipocyte disorders, intensifying the inflammatory response and contributing to the complications 
of  diabetes30.
To reinforce our data and assessment of the associated factors with GDM, we can observe that there is an 
increase in BMI, one of the precursors for insulin resistance, since during obesity there is an increase in lipids 
and there is the release of inflammatory cytokines. In addition, we emphasize that maternal age and obesity are 
factors that can directly interfere with pregnancy, contributing to the development of GDM.
Conclusions
According to the results of the present study, blood plasma samples from pregnant women with GDM could 
rapidly be differentiated from our healthy pregnant control group based on their sample FTIR spectra, where 
a chemometric model by means of the GA-LDA algorithm, was able to distinguish between GDM and healthy 
pregnant control group with 100% accuracy, sensitivity and specificity in an external test set.
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